Back
#1
18.0%
Top 0.4%
18.0%
Top 13%
11.2%
Top 65%
7.9%
Top 15%
6.5%
Top 9%
3.9%
Top 7%
2.8%
Top 3%
2.8%
Top 4%
2.0%
Top 20%
1.6%
Top 23%
1.6%
Top 11%
1.4%
Top 34%
1.4%
Top 5%
1.2%
Top 28%
1.0%
Top 7%
0.7%
Top 26%
0.7%
Top 30%
0.7%
Top 95%
0.7%
Top 19%
0.5%
Top 18%
0.5%
Cost-effectiveness of the next generation of RSV intervention strategies
2019-10-22
public and global health
Title + abstract only
View on medRxiv
Show abstract
BackgroundWith a suite of promising new RSV prophylactics on the horizon, including long-acting monoclonal antibodies and new vaccines, it is likely that one or more of these will replace the current monoclonal Palivizumab programme. However, choosing the optimal intervention programme will require balancing the costs of the programmes with the health benefits accrued. MethodsTo compare the next generation of RSV prophylactics, we integrated a novel transmission model with an economic analysis....
Predicted journal destinations
1
BMC Medicine
155 training papers
2
Vaccine
140 training papers
3
BMJ Open
553 training papers
4
PLOS ONE
1737 training papers
5
Nature Communications
483 training papers
6
Clinical Infectious Diseases
219 training papers
7
BMJ Global Health
95 training papers
8
Vaccines
131 training papers
9
PLOS Medicine
95 training papers
10
BMC Public Health
148 training papers
11
PLOS Global Public Health
287 training papers
12
The Journal of Infectious Diseases
137 training papers
13
eLife
262 training papers
14
The Lancet Infectious Diseases
57 training papers
15
Frontiers in Public Health
135 training papers
16
Public Health
34 training papers
17
BMC Infectious Diseases
110 training papers
18
JAMA Network Open
125 training papers
19
Scientific Reports
701 training papers
20
Emerging Infectious Diseases
84 training papers
21
Eurosurveillance
77 training papers